AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Intraoperative Fluid Management Guided by Internal Jugular Vein on Postoperative Complications in Abdominal Surgeries

RecruitingNAAges 20 Years - 70 YearsAllSuez Canal University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study investigates the role of respiratory variation in the internal jugular vein as a tool for intraoperative fluid management during abdominal surgeries under general anesthesia. The purpose of this clinical trial is to reduce postoperative complications and improve patient outcomes through proper intraoperative fluid management. The main question it aims to answer is: Can intraoperative fluid management guided by the respiratory variation of the internal jugular vein during abdominal surgeries reduce postoperative complications? Research Hypothesis (Alternative Hypothesis): We hypothesize that fluid management guided by the respiratory variation of the internal jugular vein during abdominal surgeries can reduce postoperative complications. The patients will be divided into two groups and randomized to receive either intraoperative fluid therapy guided by the respiratory variat

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patients' American Society of Anesthesiologists physical status (ASA) is I and II. 2. The target age group is 20 to 70 years old. 3. Patients scheduled for abdominal surgery under general anesthesia with normal renal function. Exclusion Criteria: 1. Refusal of the procedure or participation in the study. 2. Coagulopathy. 3. Pre-existing cardiac, renal, and respiratory diseases. 4-Internal jugular vein thrombosis
๐Ÿ’Š

What it tests

  • Respiratory variation of the Internal Jugular Vein (IJV)
๐Ÿ“

Where

2 sites
Suez Canal University Hospitals
Ismailia, Egypt
Suez Canal University Hospitals
Ismailia, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy